Saing, Joveimei D.

HRN: 11-23-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2026
CEFUROXIME 750MG (VIAL)
08/08/2026
08/15/2026
IV
750mg
Q8hours
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: